Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01474382 · ClinicalTrials.gov registry record · Phase 4
Study of OraVerse® for Safety and Efficacy in Pediatric Dental Patients
A Phase 4 study of Anesthesia, Local and Dental Anesthesia, sponsored by Novocol Pharmaceutical of Canada.
- Completed
- Registry status
- Phase 4
- Development phase
- 150
- Enrollment target
- 7
- Study locations
NCT01474382 is a Phase 4 study of Anesthesia, Local and Dental Anesthesia that has completed, run by Novocol Pharmaceutical of Canada. The registered enrollment target is 150 participants, above the 75-participant average among 18 other Anesthesia, Local trials with a reported enrollment target (100% higher). The trial reports 7 study locations across 6 states.
The verdict
NCT01474382, a Phase 4 study of Anesthesia, Local and Dental Anesthesia, has completed, sponsored by Novocol Pharmaceutical of Canada.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 150 participants
- Enrollment target
- 7
- Study locations
Study Summary
The purpose of this study is to determine whether OraVerse is safe and effective for the reversal of dental anesthesia in children 2 to 5 years of age weighing at least 10 kg.
Conditions Studied
Interventions
- OTHER Sham injection
- DRUG OraVerse
Study Locations (7)
Pennsylvania
- University of Pennsylvania School of Dental - Philadelphia
- University of Pittsburgh School of Dental Medicine - Pittsburgh
California
- University of California, San Francisco - San Francisco
Indiana
- Indiana University School of Dentistry - Indianapolis
Ohio
- Nationwide Children's Hospital - Columbus
Utah
- Jean Brown Research - Salt Lake City
Washington
- Center for Pediatric Dentistry - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2012-02 |
| Est. Completion | 2014-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01474382
The ClinicalTrials.gov registry entry for NCT01474382 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 75-participant average among 18 other Anesthesia, Local trials with a reported enrollment target (100% higher). The listed sponsor is Novocol Pharmaceutical of Canada, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Anesthesia, Local appearing as the primary indexed condition, and to 2 interventions - of which Sham injection is the first listed.
NCT01474382 reports 7 study locations spanning 6 distinct geographic areas - top geographies include Pennsylvania, California, Indiana.
Frequently Asked Questions
What is clinical trial NCT01474382 about?
NCT01474382 is a clinical study titled "Study of OraVerse® for Safety and Efficacy in Pediatric Dental Patients". The purpose of this study is to determine whether OraVerse is safe and effective for the reversal of dental anesthesia in children 2 to 5 years of age weighing at least 10 kg.
What is the current status of trial NCT01474382?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 150 participants. The study started on 2012-02. Estimated completion is 2014-08.
What conditions does trial NCT01474382 study?
This clinical trial studies the following conditions: Anesthesia, Local, Dental Anesthesia, Anesthesia, Reversal.
What interventions are being tested in trial NCT01474382?
The interventions under investigation include: Sham injection (OTHER), OraVerse (DRUG).
Who is sponsoring clinical trial NCT01474382?
This trial is sponsored by Novocol Pharmaceutical of Canada, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01474382 being conducted?
This trial has 7 study locations across California, Indiana, Ohio, Pennsylvania, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anesthesia, Local
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Split Face Study of the Duration of Local Anesthetics - Fourth Arm
RECRUITING · Phase 4
-
Erector Spinae Plane Block Catheters and Intrathecal Morphine for Hepatic Resection
RECRUITING · Phase 4
-
Intralipid® 20% for Reversal of Local Anesthetics
ACTIVE NOT RECRUITING · Phase 4
-
Clinical Trial Comparing Effectiveness of Buffered Versus Unbuffered Local Anesthetic in Children Ages 10-12 Years
COMPLETED · Phase 4
-
Trial of Injected Liposomal Bupivacaine vs Bupivacaine Infusion After Surgical Stabilization of Rib Fractures
COMPLETED · Phase 4
-
Liposomal Bupivacaine Versus Bupivacaine for for Postoperative Pain Control in Shoulder Surgery
COMPLETED · Phase 4
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.